Eqis Capital Management Has Increased Its Amgen (AMGN) Stake; Banco de Chile (BCH) Had 2 Bulls

Among 6 analysts covering Banco de Chile (NYSE:BCH), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Banco de Chile has $7600 highest and $71.50 lowest target. $73.63’s average target is -29.45% below currents $104.36 stock price. Banco de Chile had 11 analyst reports since August 11, 2015 according to SRatingsIntel. As per Tuesday, August 11, the company rating was upgraded by Zacks. The firm earned “Hold” rating on Wednesday, September 6 by J.P. Morgan. The rating was downgraded by JP Morgan on Friday, May 6 to “Neutral”. Scotia Capital upgraded the shares of BCH in report on Friday, July 15 to “Outperform” rating. The company was downgraded on Monday, August 15 by Standpoint Research. The rating was upgraded by Standpoint Research to “Hold” on Wednesday, August 26. The company was downgraded on Wednesday, September 6 by JP Morgan. The firm earned “Overweight” rating on Tuesday, December 13 by JP Morgan. The firm earned “Overweight” rating on Thursday, April 7 by Barclays Capital. See Banco de Chile (NYSE:BCH) latest ratings:

06/09/2017 Broker: J.P. Morgan Rating: Hold Downgrade
06/09/2017 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Downgrade

Eqis Capital Management Inc increased Amgen Inc (AMGN) stake by 5.79% reported in 2017Q3 SEC filing. Eqis Capital Management Inc acquired 1,770 shares as Amgen Inc (AMGN)’s stock declined 9.68%. The Eqis Capital Management Inc holds 32,335 shares with $6.03M value, up from 30,565 last quarter. Amgen Inc now has $139.61B valuation. The stock increased 1.61% or $3.05 during the last trading session, reaching $192.33. About 3.58 million shares traded or 28.19% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since January 23, 2017 and is uptrending. It has underperformed by 11.43% the S&P500.

Banco de Chile provides various banking services and products to individuals, corporate clients, large companies, and small and medium-sized companies in Chile and internationally. The company has market cap of $16.58 billion. The firm operates through four divisions: Retail, Wholesale, Treasury, and Subsidiaries. It has a 19.33 P/E ratio. It offers checking accounts; personal, car, and mortgage loans; credit cards; credit lines; and investment products, such as fixed-term, automatic renewal, and tax benefit deposits, as well as stocks, portfolio management, voluntary retirement savings/mutual funds, foreign currency, and fixed income investment products.

The stock increased 1.08% or $1.12 during the last trading session, reaching $104.36. About 51,274 shares traded or 21.04% up from the average. Banco de Chile (NYSE:BCH) has risen 26.52% since January 23, 2017 and is uptrending. It has outperformed by 9.82% the S&P500.

Among 24 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 13 Hold. Therefore 46% are positive. Amgen Inc. has $218 highest and $160 lowest target. $190.49’s average target is -0.96% below currents $192.33 stock price. Amgen Inc. had 75 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Argus Research on Monday, February 8 with “Buy”. Jefferies maintained the stock with “Buy” rating in Thursday, September 28 report. Oppenheimer maintained the stock with “Buy” rating in Tuesday, June 13 report. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Argus Research on Thursday, July 27. The firm has “Neutral” rating given on Wednesday, September 28 by Citigroup. Oppenheimer initiated the shares of AMGN in report on Tuesday, December 13 with “Outperform” rating. The firm has “Neutral” rating by Citigroup given on Thursday, February 25. The rating was maintained by Oppenheimer with “Buy” on Wednesday, August 16. The stock has “Overweight” rating by Piper Jaffray on Thursday, November 5. BMO Capital Markets downgraded the shares of AMGN in report on Wednesday, July 26 to “Market Perform” rating.

Since October 9, 2017, it had 0 insider purchases, and 3 selling transactions for $836,311 activity. $283,574 worth of Amgen Inc. (NASDAQ:AMGN) was sold by Harper Sean E on Monday, October 9.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: